KINGDON CAPITAL MANAGEMENT, L.L.C. - Q2 2019 holdings

$1.02 Billion is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 68 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 193.8% .

 Value Shares↓ Weighting
IWM NewISHARES TRput$134,508,000865,000
+100.0%
13.22%
QQQ NewINVESCO QQQ TRput$48,552,000260,000
+100.0%
4.77%
BHVN BuyBIOHAVEN PHARMACTL HLDG CO L$43,852,000
+0.9%
1,001,410
+18.6%
4.31%
-25.8%
MSFT BuyMICROSOFT CORP$38,656,000
+21.4%
288,567
+6.9%
3.80%
-10.8%
FCX NewFREEPORT-MCMORAN INCcl b$36,466,0003,140,882
+100.0%
3.58%
XBI NewSPDR SERIES TRUSTput$35,084,000400,000
+100.0%
3.45%
ERI BuyELDORADO RESORTS INC$33,650,000
+20.5%
730,401
+22.1%
3.31%
-11.4%
AMZN BuyAMAZON COM INC$25,833,000
+7.7%
13,642
+1.3%
2.54%
-20.9%
BABA NewALIBABA GROUP HLDG LTDsponsored ads$25,418,000150,000
+100.0%
2.50%
ZBRA NewZEBRA TECHNOLOGIES CORPcl a$25,358,000121,047
+100.0%
2.49%
ARMK NewARAMARK$23,493,000651,500
+100.0%
2.31%
COTY NewCOTY INC$22,151,0001,653,061
+100.0%
2.18%
CSTM BuyCONSTELLIUM NVcl a$20,775,000
+25.9%
2,069,219
+0.1%
2.04%
-7.4%
BA NewBOEING CO$18,524,00050,890
+100.0%
1.82%
HUYA NewHUYA INC$16,192,000655,282
+100.0%
1.59%
PFE NewPFIZER INCput$13,663,000315,400
+100.0%
1.34%
UNH NewUNITEDHEALTH GROUP INC$13,497,00055,312
+100.0%
1.33%
DIS NewDISNEY WALT CO$13,381,00095,823
+100.0%
1.32%
REGN NewREGENERON PHARMACEUTICALS$12,793,00040,871
+100.0%
1.26%
NOMD BuyNOMAD FOODS LTD$12,713,000
+12.6%
595,199
+7.8%
1.25%
-17.2%
FLXN BuyFLEXION THERAPEUTICS INC$11,426,000
+3.6%
928,924
+5.1%
1.12%
-23.9%
ATNX BuyATHENEX INC$11,245,000
+70.5%
567,935
+5.5%
1.10%
+25.3%
ZBH BuyZIMMER BIOMET HLDGS INC$11,036,000
+31.4%
93,731
+42.5%
1.08%
-3.4%
ARQL NewARQULE INC$10,855,000985,917
+100.0%
1.07%
SAFM NewSANDERSON FARMS INC$10,548,00077,238
+100.0%
1.04%
EDU NewNEW ORIENTAL ED & TECH GRP Ispon adr$9,842,000101,903
+100.0%
0.97%
CNC NewCENTENE CORP DEL$9,784,000186,583
+100.0%
0.96%
SESN BuySESEN BIO INC$9,249,000
+71.4%
6,166,175
+17.7%
0.91%
+25.9%
RPD BuyRAPID7 INC$8,724,000
+72.4%
150,825
+50.8%
0.86%
+26.7%
DIS NewDISNEY WALT COcall$8,378,00060,000
+100.0%
0.82%
AGN NewALLERGAN PLC$8,372,00050,000
+100.0%
0.82%
GTYH NewGTY TECHNOLOGY HOLDINGS INC$8,220,0001,200,000
+100.0%
0.81%
AAL NewAMERICAN AIRLS GROUP INC$7,775,000238,428
+100.0%
0.76%
DCPH BuyDECIPHERA PHARMACEUTICALS IN$6,683,000
+55.6%
296,346
+60.2%
0.66%
+14.5%
ATHM NewAUTOHOME INCput$6,370,00074,400
+100.0%
0.63%
OSW BuyONESPAWORLD HOLDINGS LIMITED$6,212,000
+338.4%
400,750
+286.2%
0.61%
+223.3%
PTCT NewPTC THERAPEUTICS INC$6,175,000137,219
+100.0%
0.61%
ADPT NewADAPTIVE BIOTECHNOLOGIES COR$5,555,000115,000
+100.0%
0.55%
ARRY NewARRAY BIOPHARMA INC$4,465,00096,380
+100.0%
0.44%
CARA NewCARA THERAPEUTICS INC$4,311,000200,500
+100.0%
0.42%
MTEM BuyMOLECULAR TEMPLATES INC$4,307,000
+44.1%
515,792
+0.3%
0.42%
+6.0%
SLGL BuySOL GEL TECHNOLOGIES$2,828,000
+74.1%
310,594
+29.4%
0.28%
+28.1%
GNCA NewGENOCEA BIOSCIENCES INC$2,612,000666,222
+100.0%
0.26%
DCPH NewDECIPHERA PHARMACEUTICALS INput$2,255,000100,000
+100.0%
0.22%
AITB NewAIT THERAPEUTICS INC$2,225,000400,859
+100.0%
0.22%
DELL BuyDELL TECHNOLOGIES INCcl c$378,000
-8.7%
7,446
+5.6%
0.04%
-32.7%
MRNA NewMODERNA INCput$157,00010,700
+100.0%
0.02%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
FLEXION THERAPEUTICS INC30Q2 20213.1%
SPDR S&P 500 ETF TR29Q3 202334.8%
ISHARES TR27Q3 202313.2%
HERON THERAPEUTICS INC23Q3 20194.2%
SOL GEL TECHNOLOGIES23Q3 20231.5%
META PLATFORMS INC22Q3 20235.9%
LIBERTY MEDIA CORP21Q4 20181.4%
NOMAD HLDGS LTD19Q3 20202.1%
AMAZON COM INC18Q3 20227.6%
SPDR SER TR18Q3 20235.0%

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.

Latest significant ownerships (13-D/G)
KINGDON CAPITAL MANAGEMENT, L.L.C. Q2 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Praxis Precision Medicines, Inc.January 25, 20232,855,9896.1%
GTY Technology Holdings Inc.February 10, 20201,598,2123.1%
Jaguar Health, Inc.February 10, 20202700.0%
Sesen Bio, Inc.February 10, 20204,040,8353.9%
Eleven Biotherapeutics, Inc.April 04, 20182,213,9805.1%
AIT Therapeutics, Inc.April 02, 2018400,8594.8%
FATE THERAPEUTICS INCSold outFebruary 14, 201800.0%
Great Elm Capital Group, Inc.February 14, 20181,267,0305.0%
HERON THERAPEUTICS, INC. /DE/February 14, 20182,179,6203.4%
Horizon Pharma plcSold outFebruary 14, 201800.0%

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-04-15
13F-HR/A2024-03-18
13F-HR2024-02-14
SC 13G/A2024-02-06
SC 13G/A2024-02-06
SC 13G/A2023-11-29
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G2023-04-13

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1017246000.0 != 1017249000.0)

Export KINGDON CAPITAL MANAGEMENT, L.L.C.'s holdings